Necrotizing meningoencephalitis (NME) is a fatal inflammatory central nervous system (CNS) disorder in dogs, where an extensive cerebral necrosis is associated with a multifocal, non-suppurative meningoencephalitis of the neuro cortex.[1][2][3] It was originally identified and recorded in the 1960s in pure breed pugs, with which this disease is nowadays mostly associated with, occurring essentially in small breed dogs ranging from six months to seven years of age.[4][2][5] It causes intense necrotizing inflammatory lesions in the brain stem and Cerebellum.[3] The cause is still unclear.[6] The pathogen that triggers the disease and contributes to its development has not yet been identified. It is presumed to have a multifactorial, heritable, autoimmune etiology.[2] The process is rapidly progressive, culminating in status epilepticus and ending fatally for the dog.[5]

Although the pattern of inflammation is similar to other neuropathological conditions, resembling CNS inflammatory diseases which produces lesions alike to those that occur in NME, a definitive diagnosis can be made solely based on by histopathological examination through a necropsy.[6]

Signs and symptoms

First signs of this immune dysregulation can show through lethargy and the reluctance to walk. Behavioral changes and an abnormal mentation might occur.[6] After a short amount of time vestibulo-cerebellar symptoms will rapidly progress, leaving the animal in a state of depressed consciousness having seizures, amaurosis and ataxia.[2][4][6]

Despite seizures being a promoting factor of necrosis in primary inflammation diseases, it's not proven that the necrosis is extending to the white matter due to these convulsions.[7]

Diagnostics

An antemortem diagnosis is often intricate considering the similarities of general neuro diagnostic profiles. To achieve a presumptive diagnosis on the live animal a multimodal approach is needed. Including the magnetic resonance imaging (MRI), computer tomography (CT), cerebrospinal liquid (CFS) analysis and immunological test. Since only the CNS is affected by the pathology, there won't be any characteristic changes in organ systems other than the nervous system.[1][2][7] Despite clinical examination methods, the specific diagnosis of NME depends on a postmortem, histopathological examination of the brain biopsy tissue or a necropsy.[3]

Histopathological features

When examining the transversal sections, the non-suppurative (lymphoplasmacytic and histiocytic) inflammation of both the meninges and encephalitis have characteristic histopathologic changes of necrotizing nature in the corona radiata (white matter), the thalamus and the cerebrocortical area.[6][8] The meninges itself is focally thickened by dense aggregations of lymphocytes, plasma cells and macrophages infiltrating due to the reinforced immune answer (perivascular cuffing).[9][10]

Several multifocal encephalic lesions in corona radiata are erasing the border in the cerebral hemispheres between white and grey matter, exposing an asymmetrical ventricular enlargement.[1] These lesions are selective with a predilection for the cerebral hemisphere.[4]

They can be divided into three phases:

Additionally, temporal lobes with dense mononuclear cells can be observed infiltrating the meninges, and cerebellar herniation through the foramen magnum,[3] which leads to neurological symptoms like continuous circling or stroke-like seizures.[6] Attempts at proving a viral etiology have been unsuccessful.[5]

Treatment

In several studies the animals were given immunosuppressive drugs, such as cytarabine, prednisolone and dexamethasone on the behalf that the cause of NME is autoimmune related. Corticosteroids inhibit T-and B-Cells and slow down the production of cytokines, which restrain the immune system from attacking its own cells but also enfeeble its natural protection – the immune answer.[10]

However, since the etiopathogenesis is still not totally understood, the inflammatory reactions are only partly reacting to the corticosteroids, such as the malacic or granulomatous changes.[10]

Prognosis

Even after several years of research, the complete pathogenesis of this disease is still not understood. Immunosuppressive and anticonvulsant drugs have extended the lives of several dogs for up to 7 months after the outbreak of the symptoms, although a complete recovery is not yet possible.

The disease remains fatal, making euthanasia an invariable necessity.[5][7]

References

  1. ^ a b c Barber RM, Schatzberg SJ, Corneveaux JJ, Allen AN, Porter BF, Pruzin JJ, Platt SR, Kent M, Huentelman MJ (1 September 2011). "Identification of risk loci for necrotizing meningoencephalitis in Pug dogs". The Journal of Heredity. 102 Suppl 1 (1): S40–6. doi:10.1093/jhered/esr048. PMID 21846746.
  2. ^ a b c d e Suzuki M, Uchida K, Morozumi M, Hasegawa T, Yanai T, Nakayama H, Tateyama S (November 2003). "A comparative pathological study on canine necrotizing meningoencephalitis and granulomatous meningoencephalomyelitis". The Journal of Veterinary Medical Science. 65 (11): 1233–9. doi:10.1292/jvms.65.1233. PMID 14665754.
  3. ^ a b c d Park ES, Uchida K, Nakayama H (July 2012). "Comprehensive immunohistochemical studies on canine necrotizing meningoencephalitis (NME), necrotizing leukoencephalitis (NLE), and granulomatous meningoencephalomyelitis (GME)". Veterinary Pathology. 49 (4): 682–92. doi:10.1177/0300985811429311. PMID 22262353.
  4. ^ a b c Cordy DR, Holliday TA (May 1989). "A necrotizing meningoencephalitis of pug dogs". Veterinary Pathology. 26 (3): 191–4. doi:10.1177/030098588902600301. PMID 2763409.
  5. ^ a b c d Greer KA, Schatzberg SJ, Porter BF, Jones KA, Famula TR, Murphy KE (June 2009). "Heritability and transmission analysis of necrotizing meningoencephalitis in the Pug". Research in Veterinary Science. 86 (3): 438–42. doi:10.1016/j.rvsc.2008.10.002. PMID 19014875.
  6. ^ a b c d e f Talarico LR, Schatzberg SJ (March 2010). "Idiopathic granulomatous and necrotising inflammatory disorders of the canine central nervous system: a review and future perspectives". The Journal of Small Animal Practice. 51 (3): 138–49. doi:10.1111/j.1748-5827.2009.00823.x. PMID 19814766.
  7. ^ a b c Kitagawa M, Okada M, Kanayama K, Sato T, Sakai T (November 2007). "A canine case of necrotizing meningoencephalitis for long-term observation: clinical and MRI findings". The Journal of Veterinary Medical Science. 69 (11): 1195–8. doi:10.1292/jvms.69.1195. PMID 18057839. S2CID 33004172.
  8. ^ Cooper JJ, Schatzberg SJ, Vernau KM, Summers BA, Porter BF, Siso S, Young BD, Levine JM (2014). "Necrotizing meningoencephalitis in atypical dog breeds: a case series and literature review". Journal of Veterinary Internal Medicine. 28 (1): 198–203. doi:10.1111/jvim.12233. PMC 4895549. PMID 24428322.
  9. ^ Higgins RJ, Dickinson PJ, Kube SA, Moore PF, Couto SS, Vernau KM, Sturges BK, Lecouteur RA (May 2008). "Necrotizing meningoencephalitis in five Chihuahua dogs". Veterinary Pathology. 45 (3): 336–46. doi:10.1354/vp.45-3-336. PMID 18487490.
  10. ^ a b c d Kuwamura M, Adachi T, Yamate J, Kotani T, Ohashi F, Summers BA (October 2002). "Necrotising encephalitis in the Yorkshire terrier: a case report and literature review". The Journal of Small Animal Practice. 43 (10): 459–63. doi:10.1111/j.1748-5827.2002.tb00014.x. PMID 12400645.
Category